The association between hepatitis B virus and membranous glomerulonephritis
and membranoproliferative glomerulonephritis (MPGN) was first described in
1971. Recently, a similar association between hepatitis C virus (HCV) and
glomerulonephritis (CN) has been reported. We investigated the prevalence o
f hepatitis C serum antibodies (anti-HCV) in patients with primary GN follo
wed up at our Nephrology Outpatient Clinic between March 1993 and November
1995. The diagnosis of primary GN was established after excluding the prese
nce of connective tissue disease, diabetes, infectious disease, and maligna
ncy. Anti-HCV antibodies were detected by a second-generation enzyme immuno
sorbent assay and HCV RNA by polymerase chain reaction. Of 81 patients with
primary GN, 24 had membranous glomerulonephritis, 17 MPGN, 15 minimal-chan
ge disease, 12 focal-segmental glomerulosclerosis, 9 diffuse proliferative
GN, and 4 IgA nephropathy. Anti-HCV were detected in 2 cases (2.5 %), both
were HCV RNA positive and had a polyclonal mixed cryoglobulinemia (IgM-IgG)
. These 2 cases both came from the group of 17 patients with MPGN. Biochemi
cal investigation in these patients revealed persistent elevation of serum
aminotransferase activity, and a liver biopsy specimen in 1 of them showed
evidence of chronic active hepatitis. We conclude that in our setting the p
revalence of anti-HCV among patients with primary GN is low, being higher (
11.8 %) only if we consider the patients with MPGN as the reference group.
Further studies are necessary to clarify this association and to determine
appropriate therapy for these patients.